The coronavirus pandemic is waning, at least from the data that many experts agree on, and Americans are starting to look forward to the beginning of the end.
The light at the end of the tunnel has always been mass vaccination, and, with a number of effective jabs now coming to market, COVID-19’s time is swiftly coming to an end.
A recent partnership between J&J and Merck will also make available a vast number of inoculations that are both single-dose and able to be stored at room temperature – a vast improvement from previous vaccines.
This has led the Biden administration to make a startling declaration.
Following the recent emergency use approval of Johnson & Johnson’s COVID-19 vaccine, all U.S. adults will be able to receive a coronavirus vaccine by the end of May, President Joe Biden announced on Tuesday.
Biden during a press conference officially announced that pharmaceutical giant Merck & Co. is teaming up with rival Johnson & Johnson to help manufacture its recently-approved COVID-19 vaccine in a bid to speed the country’s vaccination efforts, a process that began slowly but has accelerated in recent weeks.
The emergency approval of a vaccine, in addition to the collaboration between Merck and Johnson & Johnson, was key in moving the target of the vaccines being available to all adult Americans from July to the end of May, some two months sooner than initially expected. Biden credited a “stepped-up process” in seeing this timeline accelerated.
In response to the drastically dropping case numbers, Texas has decided to fully open the state’s businesses to 100% capacity next week.
Become an insider!
Sign up for our free email newsletter, and we'll make sure to keep you in the loop.